Erlotinib and Onalespib Lactate Focused on EGFR Exon 20 Insertion Non-Small Cell Lung Cancer (NSCLC): A California Cancer Consortium Phase I/II Trial (NCI 9878)
| Autor: | Riess, Jonathan W, Reckamp, Karen L, Frankel, Paul, Longmate, Jeffrey, Kelly, Karen A, Gandara, David R, Weipert, Caroline M, Raymond, Victoria M, Keer, Harold N, Mack, Philip C, Newman, Edward M, Lara, Primo N, Jr. |
|---|---|
| Zdroj: | In Clinical Lung Cancer November 2021 22(6):541-548 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect